IL28B Gene Polymorphism SNP rs8099917 Genotype GG Is Associated with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in HTLV-1 Carriers

Carregando...
Imagem de Miniatura
Citações na Scopus
26
Tipo de produção
article
Data de publicação
2014
Título da Revista
ISSN da Revista
Título do Volume
Editora
PUBLIC LIBRARY SCIENCE
Citação
PLOS NEGLECTED TROPICAL DISEASES, v.8, n.9, article ID e3199, 5p, 2014
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: The polymorphisms of IL28B have been described as important in the pathogenesis of infections caused by some viruses. The aim of this research was to evaluate whether IL28B gene polymorphisms (SNP rs8099917 and SNP rs12979860) are associated with HAM/TSP. Methods: The study included 229 subjects, classified according to their neurological status in two groups: Group I (136 asymptomatic HTLV-1 carriers) and Group II (93 HAM/TSP patients). The proviral loads were quantified, and the rs8099917 and rs12979860 SNPs in the region of IL28B-gene were analyzed by StepOnePlus Real-time PCR System. Results: A multivariate model analysis, including gender, age, and HTLV-1 DNA proviral load, showed that IL28B polymorphisms were independently associated with HAM/TSP outcome in rs12979860 genotype CT (OR = 2.03; IC95% = 0.96-4.27) and in rs8099917 genotype GG (OR = 7.61; IC95% = 1.82-31.72). Conclusion: Subjects with SNP rs8099917 genotype GG and rs12979618 genotype CT may present a distinct immune response against HTLV-1 infection. So, it seems reasonable to suggest that a search for IL28B polymorphisms should be performed for all HTLV-1-infected subjects in order to monitor their risk for disease development; however, since this is the first description of such finding in the literature, we should first replicate this study with more HTLV-1-infected persons to strengthen the evidence already provided by our results.
Palavras-chave
Referências
  1. Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004
  2. Cavalcante LN, 2012, LIVER INT, V32, P476, DOI 10.1111/j.1478-3231.2011.02653.x
  3. Chen LM, 2010, J GEN VIROL, V91, P382, DOI 10.1099/vir.0.015388-0
  4. Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1
  5. Edlich RF, 2000, J EMERG MED, V18, P109, DOI 10.1016/S0736-4679(99)00173-0
  6. Fujiyoshi T, 1999, AIDS RES HUM RETROV, V15, P1235, DOI 10.1089/088922299310124
  7. Garcia RFL, 2013, WORLD J GASTROENTERO, V19, P7399, DOI 10.3748/wjg.v19.i42.7399
  8. Ge D FJ, 2009, NATURE, V461, P3
  9. Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388
  10. HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476
  11. Hoshino H, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00222
  12. Jacobson Steven, 1997, Leukemia (Basingstoke), V11, P73
  13. Jeffery KJM, 2000, J IMMUNOL, V165, P7278
  14. Jordan WJ, 2007, GENES IMMUN, V8, P254, DOI 10.1038/sj.gene.6364382
  15. Kamihira S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-40
  16. Martin MP, 2010, J INFECT DIS, V202, P1749, DOI 10.1086/657146
  17. Montanheiro P, 2007, J NEUROIMMUNOL, V188, P138, DOI 10.1016/j.jneuroim.2007.05.015
  18. Montanheito PA, 2005, BRAZ J MED BIOL RES, V38, P1643, DOI 10.1590/S0100-879X2005001100011
  19. Montanheiro PA, 2009, SCAND J IMMUNOL, V70, P403, DOI 10.1111/j.1365-3083.2009.02291.x
  20. Moxoto I, 2007, REV SOC BRAS MED TRO, V40, P37, DOI 10.1590/S0037-86822007000100007
  21. Nagai M, 1998, J NEUROVIROL, V4, P586, DOI 10.3109/13550289809114225
  22. Pinheiro SRAA, 2006, AM J OPHTHALMOL, V142, P811, DOI 10.1016/j.ajo.2006.06.013
  23. RAUCH A, 2010, GASTROENTEROLOGY, V138, P1338, DOI 10.1053/J.GASTRO.2009.12.056
  24. Rodriguez S, 2009, AM J EPIDEMIOL, V169, P505, DOI 10.1093/aje/kwn359
  25. Sanabani SS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-374
  26. Scherzer TM, 2011, J HEPATOL, V54, P866, DOI 10.1016/j.jhep.2010.08.024
  27. Suppiah V, 2009, NAT GENET, V41, P1100, DOI 10.1038/ng.447
  28. Thio CL, 2010, GASTROENTEROLOGY, V138, P1240, DOI 10.1053/j.gastro.2010.02.033
  29. Trevino A, 2012, CLIN INFECT DIS, V55, pE1, DOI 10.1093/cid/cis343